Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Todd Dzyak, Chief Operating Officer of Widepoint Corporation (NASDAQ: WYY), executed a transaction involving the sale of 10,000 shares of the company's common stock on June 23, 2026. The sale was recorded at a price of $15.00 per share, resulting in a total transaction value of $150,000. This move comes as Widepoint's equity has experienced signifi…
John D. Quisel, Chief Executive Officer of Disc Medicine, Inc. (NASDAQ:IRON), executed a series of sales totaling approximately $2.38 million in company shares on June 18, 2026. The transactions were facilitated under a Rule 10b5-1 trading plan established in March 2026. Prior to the sales, Mr. Quisel exercised stock options for 34,000 shares at $9…
Upwork Inc. (NASDAQ: UPWK) Chief Financial Officer Erica Gessert executed a transaction involving the sale of 9,169 shares of the company's common stock on June 18, 2026. The sale, valued at $74,733, was not a discretionary trade but was conducted to cover tax withholding obligations related to the vesting of her Restricted Stock Units. This financ…
William F Griffin Jr, Non-Executive Chairman of Argan Inc (NASDAQ: AGX), executed two separate sales of the company's common stock in June 2026, realizing approximately $36.9 million. These transactions occurred while AGX stock has experienced a significant 281% increase over the past year, trading at $736.77 with a market capitalization of $10.3 b…
Bruce K. Posey, the Chief Legal Officer at Qualys, Inc. (NASDAQ:QLYS), executed a sale of company shares totaling $94,668 on June 22, 2026. The transaction involved the disposition of 865 shares traded at prices between $107.17 and $112.145, conducted under a Rule 10b5-1 trading plan established on August 21, 2025. Following this sale, Posey retain…
Mission Produce, Inc. (NASDAQ: AVO) director Bruce C. Taylor has significantly increased his indirect holdings in the company through recent transactions totaling approximately $1.13 million. The acquisitions were executed over two days in June 2026, with prices ranging between $11.25 and $11.36 per share. This insider activity occurs as Mission Pr…
Fairholme Funds Inc. and its controlling principal Bruce R. Berkowitz executed a coordinated sale of St. Joe Co (NASDAQ:JOE) equity, offloading approximately $9.23 million in common stock. The transaction, which reduced their collective ownership stakes, follows a period of significant price appreciation for the real estate developer. While the fir…
Qualys, Inc. (NASDAQ:QLYS) director Wendy Pfeiffer sold 500 shares of company stock on June 22, 2026, according to a filing with the Securities and Exchange Commission. The transaction, valued at $55,275, was executed under a Rule 10b5-1 trading plan adopted earlier in the year. This sale follows a period of strong financial performance for the cyb…
Matthew Angel, Chief Executive Officer and President of Tempest Therapeutics, Inc. (NASDAQ: TPST), has acquired approximately $500,001 worth of the company's common stock through an indirect purchase. The transaction, reported via a Form 4 filing with the Securities and Exchange Commission on June 23, 2026, occurred on March 24, 2026. Angel, who al…
Tami Rosen, a director at Pagaya Technologies Ltd. (NASDAQ: PGY), executed a sale of 9,944 Class A Ordinary Shares on June 22, 2026, realizing a total value of $151,131. The transaction, conducted at prices ranging from $15.00 to $16.27 per share with a weighted average of $15.1983, leaves Ms. Rosen with a direct holding of 37,544 shares. This insi…
Hinge Health, Inc. (NASDAQ:HNGE) President James Pursley completed a divestment of 33,000 Class A Common Stock shares on June 22, 2026, generating proceeds of approximately $2,287,251. The transaction, executed under a pre-arranged Rule 10b5-1 trading plan adopted in June 2025, took place as the company's equity approached its 52-week peak of $71.4…
Jennifer Noel Harris, a director at Brilliant Earth Group, Inc. (NASDAQ:BRLT), sold 38,356 shares of the company's Class A Common Stock over two separate transactions last week. The sales, valued at approximately $40,307, were conducted under a Rule 10b5-1 trading plan established in August 2025. This insider activity coincides with BRLT trading ne…
Amplify Energy Corp. (NASDAQ: AMPY) reported a recent insider acquisition as President and Chief Financial Officer James Frew purchased 25,000 shares of the company’s common stock on June 23, 2026. The transaction, valued at $98,750, brings Mr. Frew’s direct holdings to 216,859 shares. The purchase follows a period of market pressure that has pushe…
Mark T. Walsh, Chief Executive Officer and Director at Savers Value Village, Inc. (NASDAQ:SVV), sold 41,600 shares of the company's common stock on June 18, 2026. The transaction, valued at $419,199, was conducted under a Rule 10b5-1 trading plan adopted in March 2026. Following the sale, Walsh retains direct ownership of 47,363 shares. The sale oc…
Datadog, Inc. (NASDAQ:DDOG) Director Amit Agarwal sold 20,000 shares of the company's Class A Common Stock on June 18, 2026, generating approximately $4.4 million. The transaction was conducted through a pre-arranged 10b5-1 trading plan established in March 2026. This sale followed the conversion of 20,000 Class B shares into Class A shares on the …
Mark A. Stevens, a director at NVIDIA Corp. (NASDAQ:NVDA), has executed a significant divestment through trusts he co-trusts, selling 885,000 shares of NVIDIA common stock on June 18, 2026. The transactions total approximately $186 million. Despite the sale, Stevens retains substantial indirect and direct holdings in the company. The divestment occ…
Robert Lonergan, Executive Vice President and Chief Strategy and Transformation Officer at Assurant, Inc. (AIZ), executed a sale of 7,000 shares on June 22, 2026, valued at approximately $1,838,967. The transaction was facilitated through a Rule 10b5-1 trading plan established on March 20, 2026. The shares were divested at a weighted average price …
Heather Brianne Dixon, President and Chief Operating Officer of Addus HomeCare Corp (NASDAQ: ADUS), executed a transaction to sell 288 shares of the company's common stock on June 22, 2026. The sale, valued at $27,005, was conducted at a price of $93.77 per share. This transaction was facilitated through a pre-established 10b5-1 trading plan, which…
Cadre Holdings, Inc. (NASDAQ:CDRE) Chief Executive Officer and Chairman Warren B. Kanders recently divested a substantial portion of his equity stake in the firm, selling 75,000 shares through his affiliated entity, Kanders SAF, LLC. These transactions, valued at approximately $2.07 million, occurred as the company's stock traded near its 52-week l…
Shachar Erez, a director at fraud prevention company Riskified Ltd., has executed a series of sales totaling $870,811 in Class A Ordinary Shares. The transactions, conducted through entities affiliated with Qumra Capital, were carried out under a Rule 10b5-1 trading plan. This activity occurs as the company manages regulatory procedures for a signi…
Mark Barrocas, Chief Executive Officer of SharkNinja, Inc. (NYSE:SN), executed a significant transaction on June 18, 2026, by selling 100,000 ordinary shares. The divestment generated $14,000,000 based on a per-share price of $140.00. Post-transaction, Barrocas retains direct ownership of 2,346,659 ordinary shares. The sale occurs against a backdro…
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) reported a significant insider transaction involving its Chief Legal & Compliance Officer, Rahsaan Thompson. On June 22, 2026, Thompson sold 34,557 shares of common stock, realizing a total value of $438,303. This sale occurred shortly after the vesting and settlement of restricted stock units (RSUs) on June …
Basswood Capital Management, L.L.C., alongside multiple affiliated funds and individuals, executed a significant divestment of Dime Commercial Bancshares, Inc. (NASDAQ: DCOM) stock, totaling $1.28 million. The transactions, finalized on June 18, 2026, involved the sale of 32,751 shares at $39.02 apiece. This activity occurs as Dime Commercial Bancs…
Joshua T. Brumm, Chief Executive Officer of Crescent Biopharma, Inc. (NASDAQ:CBIO), executed a sale of 42,305 ordinary shares on June 22, 2026, generating approximately $761,066. The divestment was conducted to satisfy tax withholding obligations related to the vesting of restricted stock units granted in late 2025. The transactions were facilitate…
Rudy Austin, a director and significant shareholder of Bonk, Inc. (BNKK), has executed multiple purchases of the company's common stock, bringing his indirect holdings to 73,341 shares. The transactions, facilitated through Nom Capital ULC, occurred as Bonk reported first-quarter 2026 revenue that exceeded internal targets. The company also highlig…
